Cargando…
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
Safe and efficient drugs to combat the current COVID-19 pandemic are urgently needed. In this context, we have analyzed the anti-coronavirus potential of the natural product glycyrrhizic acid (GLR), a drug used to treat liver diseases (including viral hepatitis) and specific cutaneous inflammation (...
Autores principales: | Bailly, Christian, Vergoten, Gérard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311916/ https://www.ncbi.nlm.nih.gov/pubmed/32592716 http://dx.doi.org/10.1016/j.pharmthera.2020.107618 |
Ejemplares similares
-
Mechanism of action of glycyrrhizin against Plasmodium falciparum
por: Soeiro, Maria de Nazaré Correia, et al.
Publicado: (2021) -
Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study
por: Bailly, Christian, et al.
Publicado: (2023) -
Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis
por: Bailly, Christian, et al.
Publicado: (2020) -
Anticancer Properties and Mechanism of Action of Oblongifolin C, Guttiferone K and Related Polyprenylated Acylphloroglucinols
por: Bailly, Christian, et al.
Publicado: (2021) -
Interaction of obtusilactone B and related butanolide lactones with the barrier-to-autointegration factor 1 (BAF1). A computational study
por: Bailly, Christian, et al.
Publicado: (2021)